发明名称 |
miR-31 in duchenne muscular dystrophy therapy |
摘要 |
The invention relates to the therapy of Duchenne Muscular Dystrophy (DMD) by means of modulating the amount of a specific miRNA (miR-31). |
申请公布号 |
US9034838(B2) |
申请公布日期 |
2015.05.19 |
申请号 |
US201013322023 |
申请日期 |
2010.05.24 |
申请人 |
UNIVERSITA DEGLI STUDI DI ROMA “LA SAPIENZA” |
发明人 |
Bozzoni Irene;Martone Julie;Cacchiarelli Davide;Incitti Tania |
分类号 |
C12Q1/68;C12N15/113 |
主分类号 |
C12Q1/68 |
代理机构 |
Lucas & Mercanti, LLP |
代理人 |
Lucas & Mercanti, LLP |
主权项 |
1. A nucleic acid molecule or a derivative thereof wherein the derivative is a DNA molecule coding the nucleic acid molecule and wherein the nucleic acid molecule is:
5′ggcagcuauguuugcaucuugccucacacagcuauguuugcaucuugccucacacagcuauguuugcaucuugccucaca cagcuauguuugcaucuugccuccgc-3′(SEQ ID NO: 4), 5′-gaaauggcaaguuau-3′(SEQ ID NO: 1) or 5′-ccauauaaagaaauggcaaguua-3′ (SEQ ID NO: 2). |
地址 |
Rome IT |